NeuExcell Therapeutics

1 follower


NeuExcell is an early stage gene therapy company focusing on neurodegenerative diseases. They have developed a disruptive neural repair technology that utilizes in vivo astrocyte-to-neuron conversion.

Industries

Employees

11-50

Links


Org chart

Collapse
Jie Xu
Co-Founder & Head of Discovery
Josephine Yang
CFO, China
J. David Jacobs
General Counsel & SVP
Yuchen Chen
VP, R&D, China
Kun (Quinn) Yao
Vice President (VP), Head of CMC and Tech Ops
Egor Zhelezniak
Head Of HR (director)
Tsang-Chih Kuo
Director, CMC Department

Board & advisors

Xudong Yin
Board Chair
Gong Chen
Co-Founder, Chief Scientific Advisor & Director
Peter Tombros
Board Director
Jonathan Sun
Director
Xin Huang
Director